Treatment of Elevated Ferritin Levels

Initial Assessment and Diagnosis

Transferrin saturation (TSAT) should be measured alongside ferritin to differentiate iron overload from inflammatory states, with TSAT >45-50% suggesting true iron overload and TSAT <20% with elevated ferritin indicating functional iron deficiency or inflammation, according to the American Association for the Study of Liver Diseases 1, 2, 3
The European Association for the Study of the Liver recommends screening for hereditary hemochromatosis (HFE) with genetic testing if TSAT is elevated and clinical suspicion exists 1

The American College of Gastroenterology recommends phlebotomy as the primary treatment for HFE hemochromatosis, with a target serum ferritin <50 μg/L during the depletion phase to achieve iron deficiency and normalize tissue iron 1
The American Society of Hematology suggests maintenance therapy with phlebotomy every 3-6 months to maintain ferritin at 50-100 μg/L after depletion 1
For ferroportin disease, the National Hematologic Society recommends treatment with repeated phlebotomies, with extended intervals if anemia develops despite elevated ferritin 4

The American Society of Hematology recommends initiating chelation when serum ferritin reaches ≥1000 μg/L in patients requiring ≥2 units/month for >1 year, or when organ preservation is needed, with deferasirox as the primary agent 5, 6
The International Society of Nephrology suggests monitoring serum ferritin monthly and adjusting the dose of deferasirox to achieve decreasing trends, with a maximum dose of 28 mg/kg/day 5, 6

The National Kidney Foundation recommends not withholding IV iron solely based on elevated ferritin if TSAT is low (<25%) and the patient is on erythropoiesis-stimulating agents (ESAs) with inadequate hemoglobin response, and maintaining TSAT >20% and ferritin >200 ng/mL in hemodialysis patients receiving ESAs to optimize anemia correction and reduce ESA requirements 2, 3, 7
The American Society of Nephrology suggests temporarily withholding IV iron if TSAT chronically >50% or ferritin >800-1000 ng/mL, and monitoring ferritin every 3 months minimum, monthly if possible, in transfusion-dependent patients 8, 2, 3

The Pediatric Society recommends avoiding overchelation, as continued chelation when ferritin approaches normal range can result in life-threatening adverse events, and interrupting chelation during volume depletion and resuming only when renal function and hydration normalize 4